Patient Nanyanyiso Baloi holds her treatment regimen for pre-XDR-TB, which includes delamanid and bedaquiline. Khayelitsha, Western Cape.
All Topics

Drug-resistant TB

 
Drug-resistant TB

Global leaders must make bold commitments at first-ever UN Tuberculosis Summit

Press Release 25 Sep 2018
 
Drug-resistant TB

MSF response to release of WHO’s Global Tuberculosis Report 2018

Press Release 19 Sep 2018
 
Briefing Document

The UN High- Level Meeting on Tuberculosis

19 Sep 2018
Briefing Document
 
Drug-resistant TB

TB Summit: What you need to know

Latest News 12 Sep 2018
 
Drug-resistant TB

MSF applauds the World Health Organization’s move to recommend improved tuberculosis treatment options

Press Release 17 Aug 2018
 
Zimbabwe

MSF Zimbabwe Newsletter: June 2018

Newsletter 2 Jul 2018